Alprostadil (Injectable): Uses, Mechanism, Dosage, Side Effects, Safety Guidelines, and FAQs

By /

Alprostadil — Comprehensive Medical Overview

Introduction

Alprostadil is a synthetic version of prostaglandin E1 (PGE1), a naturally occurring prostaglandin involved in multiple physiological processes including vasodilation, inhibition of platelet aggregation, and modulation of smooth muscle tone. Medically, alprostadil is used primarily for its potent vasodilatory properties to treat erectile dysfunction (ED), maintain patency of the ductus arteriosus in neonates with congenital heart defects, and to improve peripheral circulation.

This article provides an extensive review of alprostadil’s pharmacology, clinical uses, dosing, administration methods, safety profile, contraindications, drug interactions, and clinical considerations.

Uses & Indications

1. Erectile Dysfunction (ED):
Alprostadil is indicated for treatment of erectile dysfunction in men when oral phosphodiesterase type 5 inhibitors are contraindicated or ineffective. It helps produce and maintain penile erection by increasing blood flow.

2. Maintenance of Patent Ductus Arteriosus (PDA) in Neonates:
In neonates with certain congenital heart defects, alprostadil is administered intravenously to maintain ductus arteriosus patency, allowing adequate systemic or pulmonary blood flow until corrective surgery.

3. Peripheral Vascular Diseases (Off-label):
Alprostadil may be used to improve blood flow in patients with peripheral arterial occlusive disease or critical limb ischemia.

4. Other Uses:
Occasionally employed in vascular surgery or interventional radiology for vasodilation.

Mechanism of Action

Alprostadil mimics endogenous prostaglandin E1, exerting its pharmacological effect through:

  • Activation of adenylate cyclase in vascular smooth muscle cells, leading to increased intracellular cyclic AMP (cAMP).
  • cAMP mediates smooth muscle relaxation, causing vasodilation of blood vessels.
  • In penile tissue, this vasodilation enhances arterial inflow and reduces venous outflow, resulting in an erection.
  • In the ductus arteriosus, it prevents closure by relaxing smooth muscle, maintaining blood flow between the aorta and pulmonary artery.

Pharmacokinetics

  • Absorption:
    Varies with administration route (intracavernosal, intraurethral, intravenous). Intracavernosal and intraurethral routes provide localized effect with minimal systemic absorption.
  • Distribution:
    Rapidly distributed, mainly acting locally; systemic exposure is transient.
  • Metabolism:
    Quickly metabolized by pulmonary vasculature and liver, resulting in a short half-life.
  • Elimination:
    Metabolites are excreted primarily via urine.
  • Half-life:
    Approximately 5-10 minutes; necessitates repeated or continuous dosing depending on indication.

Dosage and Administration

Formulations:

  • Intracavernosal Injection: Sterile alprostadil solution injected directly into the corpora cavernosa.
  • Intraurethral Suppository (MUSE): Small pellets inserted into the urethra.
  • Intravenous Infusion: For neonates to maintain PDA.

1. Erectile Dysfunction Dosing:

  • Intracavernosal Injection:
    Initial dose: 2.5 to 20 micrograms per injection.
    Dose titrated based on response and side effects.
    Maximum frequency: once daily, no more than 3 times per week recommended.
  • Intraurethral Suppository:
    Initial dose: 125 to 250 micrograms inserted into the urethra.
    Dose may be increased to 500 micrograms if needed.

2. Neonatal PDA Maintenance:

  • Starting dose: 0.05 to 0.1 micrograms/kg/min IV infusion.
  • Titrated based on clinical response to maintain ductal patency.
  • Continuous monitoring in ICU setting required.

Side Effects

Erectile Dysfunction:

  • Pain or burning at injection/insertion site.
  • Penile fibrosis or scarring (rare).
  • Priapism (prolonged erection >4 hours, medical emergency).
  • Urethral bleeding or minor discharge (with intraurethral use).
  • Dizziness, hypotension (rare systemic effects).

Neonatal Use:

  • Apnea or respiratory depression.
  • Hypotension or bradycardia.
  • Fever or flushing.

General:

  • Allergic reactions (rare).
  • Headache.

Warnings and Precautions

  • Priapism Risk:
    Immediate medical attention required if erection lasts >4 hours to prevent tissue damage.
  • Cardiovascular Considerations:
    Use cautiously in patients with severe cardiovascular disease.
  • Neonatal Monitoring:
    Continuous cardiorespiratory monitoring required.
  • Allergic Reactions:
    Discontinue if hypersensitivity occurs.
  • Avoid concurrent use with nitrates or other vasodilators that may exacerbate hypotension.

Drug Interactions

  • Nitrates and PDE5 inhibitors: Concurrent use contraindicated due to risk of severe hypotension.
  • Antihypertensives: Additive hypotensive effect possible.
  • Blood thinners: No direct interaction but monitor for bleeding if injection site trauma occurs.

Clinical Efficacy

  • Multiple studies confirm alprostadil’s efficacy in producing erections sufficient for intercourse in men with ED refractory to oral agents.
  • Neonatal use is life-saving by maintaining ductus arteriosus until corrective procedures.
  • Off-label peripheral vascular uses show some benefit but require more evidence.

Patient Counseling

  • Proper technique for injection or suppository use is essential to minimize complications.
  • Warn about potential side effects and the importance of seeking emergency care for priapism.
  • Inform about storage requirements (refrigeration) and handling of medication.
  • Emphasize adherence to prescribed dosing schedule.
  • Educate caregivers of neonates on monitoring requirements.

FAQs

Q1: How quickly does alprostadil work for ED?
A: Onset is typically within 5 to 20 minutes after injection or urethral insertion.

Q2: Can I use alprostadil with oral ED medications?
A: Usually not recommended due to increased risk of side effects; consult your doctor.

Q3: What should I do if I experience priapism?
A: Seek immediate emergency medical attention to prevent permanent damage.

Q4: Is alprostadil safe for children?
A: Its use in neonates is specialized for PDA maintenance under strict supervision.

Q5: How should alprostadil be stored?
A: Store refrigerated and protect from light; follow specific product instructions.

Summary

Alprostadil is a versatile prostaglandin analog with critical applications in erectile dysfunction and neonatal cardiac care. Its potent vasodilatory effects enable targeted therapeutic benefits but require careful administration and monitoring to avoid adverse outcomes. Through appropriate use, alprostadil significantly improves quality of life and clinical outcomes in its approved indications.

References

  1. Alprostadil [Prescribing Information]. Meda Pharmaceuticals; 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020453s025lbl.pdf
  2. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of erectile dysfunction. J Urol. 2018;200(3):633-641.
  3. Rao PS, Webber SA. Prostaglandin E1 for ductus arteriosus patency: indications and complications. Pediatr Cardiol. 2005;26(1):26-33.
  4. MedlinePlus. Alprostadil injection and suppository. https://medlineplus.gov/druginfo/meds/a682624.html
  5. Mayo Clinic. Erectile dysfunction treatments. https://www.mayoclinic.org/diseases-conditions/erectile-dysfunction/diagnosis-treatment/drc-20355776

Table of Contents

→ Index
Scroll to Top